SPOTLIGHT: Lexicon gains $20M in milestones

Lexicon Genetics has received two milestone payments totaling $20 million from Genentech for their collaboration on drug development. The payments cover their work in proteins and antibodies. Report

Suggested Articles

Reich co-founded Effector and served as its SVP of research but has moved on to take up the CSO position at Turning Point Therapeutics.

BioMarin’s hemophilia A drug has been set an Aug. 21 PDUFA date as the California biotech looks to gain a speedy approval.

Roche talked up its ability to cope with the loss of the R&D chief, pointing to the 450-person team High helped build to back up its confidence.